Company Filing History:
Years Active: 2022-2024
Title: Bo Mi Park - Innovator in Pharmaceutical Compositions
Introduction
Bo Mi Park is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating various diseases. With a total of 2 patents to his name, Park's work focuses on innovative solutions for retinal and diabetic conditions.
Latest Patents
Park's latest patents include a pharmaceutical composition comprising an adenosine derivative for the prevention and treatment of retinal disease or optic nerve disease. This invention relates to a pharmaceutical composition, an oral administration agent, and an eye drop that effectively prevent or treat retinal diseases or optic nerve diseases. The active ingredient is represented by a specific chemical formula or a pharmaceutically acceptable salt thereof. Another significant patent is a pharmaceutical composition for preventing and treating diabetic nephropathy, which also includes an adenosine derivative compound as an active ingredient.
Career Highlights
Bo Mi Park is currently associated with Future Medicine Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving health outcomes through advanced medical solutions.
Collaborations
Park collaborates with talented individuals in his field, including Chong-Woo Park and Mi Ra Yu. Their combined expertise contributes to the success of their projects and the advancement of pharmaceutical research.
Conclusion
Bo Mi Park is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of retinal diseases and diabetic nephropathy. His innovative approach and dedication to research exemplify the spirit of invention in the medical field.